BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 627723)

  • 1. Defective tumoricidal capacity of macrophages from C3H/HeJ mice.
    Ruco LP; Meltzer MS
    J Immunol; 1978 Jan; 120(1):329-34. PubMed ID: 627723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective tumoricidal capacity of macrophages from P/J mice: characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli.
    Boraschi D; Meltzer MS
    J Immunol; 1980 Aug; 125(2):771-6. PubMed ID: 6993562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The activation of tumoricidal properties in macrophages of endotoxin responder and nonresponder mice by liposome-encapsulated immunomodulators.
    Fogler WE; Talmadge JE; Fidler IJ
    J Reticuloendothel Soc; 1983 Mar; 33(3):165-74. PubMed ID: 6834360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective tumoricidal capacity of macrophages from A/J mice. I. Characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli.
    Boraschi D; Meltzer MS
    J Immunol; 1979 Apr; 122(4):1587-91. PubMed ID: 376720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of activated macrophages in C3H/HeJ mice by avirulent Salmonella.
    Schafer R; Nacy CA; Eisenstein TK
    J Immunol; 1988 Mar; 140(5):1638-44. PubMed ID: 3279120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-induced enhancement of macrophage-mediated tumor cytolysis and its difference from activation by lymphokines.
    Boraschi D; Tagliabue A
    Eur J Immunol; 1981 Feb; 11(2):110-4. PubMed ID: 6163639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective Fc-mediated phagocytosis in C3H/HeJ macrophages. II. Correction by cAMP agonists.
    Vogel SN; Weedon LL; Oppenheim JJ; Rosenstreich DL
    J Immunol; 1981 Feb; 126(2):441-5. PubMed ID: 6256439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophages as effector cells of protective immunity in murine schistosomiasis. V. Variation in macrophage schistosomulacidal and tumoricidal activities among mouse strains and correlation with resistance to reinfection.
    James SL; Skamene E; Meltzer MS
    J Immunol; 1983 Aug; 131(2):948-53. PubMed ID: 6863937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage stimulation by bacterial lipopolysaccharides. III. Selective unresponsiveness of C3H/HeJ macrophages to the lipid A differentiation signal.
    Doe WF; Henson PM
    J Immunol; 1979 Nov; 123(5):2304-10. PubMed ID: 385780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LPS regulation of the immune response: separate mechanisms for murine B cell activation by lipid A (direct) and polysaccharide (macrophage-dependent) derived from Bacteroides LPS.
    Williamson SI; Wannemuehler MJ; Jirillo E; Pritchard DG; Michalek SM; McGhee JR
    J Immunol; 1984 Nov; 133(5):2294-300. PubMed ID: 6332842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of genetic defects in macrophage tumoricidal capacity: identification of murine strains with abnormalities in secretion of cytolytic factors and ability to bind neoplastic targets.
    Adams DO; Marino PA; Meltzer MS
    J Immunol; 1981 May; 126(5):1843-7. PubMed ID: 6783698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage activation for tumor cytotoxicity: induction of tumoricidal macrophages by supernatants of PPD-stimulated Bacillus Calmette-GuĂ©rin-immune spleen cell cultures.
    Ruco LP; Meltzer MS
    J Immunol; 1977 Sep; 119(3):889-96. PubMed ID: 330759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines, or interferon-gamma.
    Stuehr DJ; Marletta MA
    J Immunol; 1987 Jul; 139(2):518-25. PubMed ID: 3110273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective tumoricidal capacity of macrophages from A/J mice. II. Comparison of the macrophage cytotoxic defect of A/J mice with that of lipid A-unresponsive C3H/HeJ mice.
    Boraschi D; Meltzer MS
    J Immunol; 1979 Apr; 122(4):1592-97. PubMed ID: 376721
    [No Abstract]   [Full Text] [Related]  

  • 15. BCG-induced enhancement of endotoxin sensitivity in C3H/HeJ mice. I. In vivo studies.
    Vogel SN; Moore RN; Sipe JD; Rosenstreich DL
    J Immunol; 1980 Apr; 124(4):2004-9. PubMed ID: 6154089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic properties of bacterial lipopolysaccharide (LPS). IV. Cellular basis of the unresponsiveness of C3H/HeJ mouse spleen cells to LPS-induced mitogenesis.
    Skidmore BJ; Chiller JM; Weigle WO
    J Immunol; 1977 Jan; 118(1):274-81. PubMed ID: 299760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid A-associated proteins provide an alternate "second signal" in the activation of recombinant interferon-gamma-primed, C3H/HeJ macrophages to a fully tumoricidal state.
    Hogan MM; Vogel SN
    J Immunol; 1987 Dec; 139(11):3697-702. PubMed ID: 3119714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Induction of activated macrophages by intraperitoneal injection of mitomycin C in mice and rats].
    Ogura T
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):689-96. PubMed ID: 3083782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of tumor necrosis factor by rIFN-gamma-primed C3H/HeJ (Lpsd) macrophages requires the presence of lipid A-associated proteins.
    Hogan MM; Vogel SN
    J Immunol; 1988 Dec; 141(12):4196-202. PubMed ID: 3143760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between murine macrophage Fc receptor-mediated phagocytic function and competency for activation for non-specific tumor cytotoxicity.
    Leu RW; Rummage JA; Rahimi MB; Herriott MJ
    Immunobiology; 1986 Apr; 171(3):220-33. PubMed ID: 3519439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.